PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 27539098-5 2016 SHR-CRP rats treated with fenofibrate alone (100 mg/kg body weight) or in combination with rosuvastatin (20 mg/kg body weight) vs. SHR-CRP untreated controls showed increased levels of proinflammatory marker IL6, increased concentrations of ALT, AST and ALP, increased oxidative stress in the liver and necrotic changes of the liver. Rosuvastatin Calcium 91-103 interleukin 6 Rattus norvegicus 208-211 33917884-7 2021 Rosuvastatin/Lactobacillus showed prominent anti-inflammatory effects as revealed by the IL-10/IL-12 ratio and the levels of TNF-alpha and IL-6. Rosuvastatin Calcium 0-12 interleukin 6 Rattus norvegicus 139-143 34226988-7 2021 Beyond lipid lowering, rosuvastatin treatment reduced total and differential WBC counts in the A and AH groups (p<0.05 to p<0.001), IL-6 level in the AH group (p<0.05), and IL-10 level in all treated groups (p<0.05). Rosuvastatin Calcium 23-35 interleukin 6 Rattus norvegicus 132-136 33641435-8 2021 Administration of rosuvastatin reduced the increases in expression of NLRP3, ASC, pro-caspase-1, TLR4, and p65 and decreased the contents of TNF-alpha, IL-1beta, IL-18 and IL-6, with a similar effect as MCC950 (NLRP3 inhibitor). Rosuvastatin Calcium 18-30 interleukin 6 Rattus norvegicus 172-176 30519383-11 2018 Rosuvastatin use also resulted in reduction of TNF-alpha, IL-6, and MDA levels. Rosuvastatin Calcium 0-12 interleukin 6 Rattus norvegicus 58-62 23295058-8 2013 Further study revealed that rosuvastatin significantly decreased hepatic mRNA expression of tumour necrosis factor-alpha and interleukin-6, serum alanine aminotransferase levels and hepatic lobular inflammation grade. Rosuvastatin Calcium 28-40 interleukin 6 Rattus norvegicus 125-138 19147451-7 2009 Furthermore, rosuvastatin reduced the increased IL-6 level and further elevated IL-10 level in the peri-infarct and remote zones of MI. Rosuvastatin Calcium 13-25 interleukin 6 Rattus norvegicus 48-52 21915500-10 2011 Rosuvastatin increased the nitric oxide level in the L-name+rosuvastatin-2 group and reduced the interleukin-6 and tumor necrosis factor alpha levels, glomerular macrophage number and albumin:urinary creatinine ratio in the L-name+rosuvastatin-20 and L-name+rosuvastatin-2 groups. Rosuvastatin Calcium 0-12 interleukin 6 Rattus norvegicus 97-142 20121625-6 2010 Rosuvastatin pretreatment appears to protect these organs after hepatic I/R injury through the reduction of proinflammatory cytokines (TNF-alpha, IL-6, and MCP-1) and stimulation of anti-inflammatory cytokines (IL-10) production. Rosuvastatin Calcium 0-12 interleukin 6 Rattus norvegicus 146-150